Control of influenza in the long-term-care facility: A review of established approaches and newer options

被引:40
作者
Arden, NH [1 ]
机构
[1] Baylor Coll Med, Dept Microbiol & Immunol, Houston, TX 77030 USA
关键词
D O I
10.1086/501702
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Influenza infections pose a serious threat to residents of nursing homes and other long-term-care facilities. Annual vaccination of residents and staff with the currently licensed inactivated influenza vaccine continues to be the mainstay of prevention. Live attenuated influenza vaccine, which is expected to be licensed in the United Slates in the near future, may offer added protection for elderly persons when administered in conjunction with inactivated vaccine. Antiviral agents also can be useful as an adjunct to vaccination, especially for control of institutional outbreaks. Two new antiviral agents that appear to be less toxic than amantadine and rimantadine have recently been approved (Infect Control Hosp Epidemiol 2000;21:59-64).
引用
收藏
页码:59 / 64
页数:6
相关论文
共 63 条
[1]  
[Anonymous], 1999, MMWR Recomm Rep, V48, P1
[2]  
[Anonymous], 1986, OPTIONS CONTROL INFL
[3]  
AOKI FY, 1998, 38 INT C ANT AG CHEM
[4]   VACCINE USE AND THE RISK OF OUTBREAKS IN A SAMPLE OF NURSING-HOMES DURING AN INFLUENZA EPIDEMIC [J].
ARDEN, N ;
MONTO, AS ;
OHMIT, SE .
AMERICAN JOURNAL OF PUBLIC HEALTH, 1995, 85 (03) :399-401
[5]   SAFETY AND IMMUNOGENICITY OF A 45-MU-G SUPPLEMENTAL DOSE OF INACTIVATED SPLIT-VIRUS INFLUENZA-B VACCINE IN THE ELDERLY [J].
ARDEN, NH ;
PATRIARCA, PA ;
LUI, KJ ;
HARMON, MW ;
BRANDON, F ;
KENDAL, AP .
JOURNAL OF INFECTIOUS DISEASES, 1986, 153 (04) :805-806
[6]   THE ROLES OF VACCINATION AND AMANTADINE PROPHYLAXIS IN CONTROLLING AN OUTBREAK OF INFLUENZA-A (H3N2) IN A NURSING-HOME [J].
ARDEN, NH ;
PATRIARCA, PA ;
FASANO, MB ;
LUI, KJ ;
HARMON, MW ;
KENDAL, AP ;
RIMLAND, D .
ARCHIVES OF INTERNAL MEDICINE, 1988, 148 (04) :865-868
[7]   The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children [J].
Belshe, RB ;
Mendelman, PM ;
Treanor, J ;
King, J ;
Gruber, WC ;
Piedra, P ;
Bernstein, DI ;
Hayden, FG ;
Kotloff, K ;
Zangwill, K ;
Iacuzio, D ;
Wolff, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (20) :1405-1412
[8]   ANTIBODY INDUCTION BY INFLUENZA VACCINES IN THE ELDERLY - A REVIEW OF THE LITERATURE [J].
BEYER, WEP ;
PALACHE, AM ;
BALJET, M ;
MASUREL, N .
VACCINE, 1989, 7 (05) :385-394
[9]  
*BIOST INC, 1999, FLU OIA PROD PACK IN
[10]   Generation and characterization of an influenza virus neuraminidase variant with decreased sensitivity to the neuraminidase-specific inhibitor 4-guanidino-Neu5Ac2en [J].
Blick, TJ ;
Tiong, T ;
Sahasrabudhe, A ;
Varghese, JN ;
Colman, PM ;
Hart, GJ ;
Bethell, RC ;
McKimmBreschkin, JL .
VIROLOGY, 1995, 214 (02) :475-484